Search

Your search keyword '"Nevirapine -- Research"' showing total 96 results
Start Over Descriptor "Nevirapine -- Research"
96 results on '"Nevirapine -- Research"'

1. Studies from Durban University of Technology Have Provided New Data on Antivirals [Exploring Chlorination As a Removal Process for Antiretroviral Drugs (Nevirapine and Efavirenz) From Water: Effect of Operational Parameters, Kinetics, and ...]

Subjects
Drinking water -- Research, Efavirenz -- Research, Drugs -- Research, Highly active antiretroviral therapy -- Research, Nevirapine -- Research, Physical fitness -- Research
Abstract

2024 NOV 16 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Investigators publish new report on Drugs and Therapies - Antivirals. According to [...]

Published
2024

2. New Findings on Antivirals Described by Investigators at Oswaldo Cruz Foundation (FIOCRUZ) (Life Cycle Application of Aqbd for Formulation Development and Validation of a Dissolution Method for Nevirapine)

Subjects
Research, Reports, Methods, Physical fitness -- Research -- Methods -- Reports, Nevirapine -- Research, Antiretroviral agents -- Research, Product life cycle -- Methods -- Research -- Reports, Antiviral agents -- Research
Abstract

2024 OCT 5 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- A new study on Drugs and Therapies - Antivirals is now available. [...]

Published
2024

3. Reports on Antivirals Findings from University of Johannesburg Provide New Insights (Enhanced Biocatalytic Degradation of Nevirapine In Water With Immobilised Cross-linked Laccase and Tyrosinase Embedded Within a Membrane)

Subjects
Antiviral agents -- Research, Highly active antiretroviral therapy -- Research -- Analysis -- Reports, Oxidases -- Reports -- Research -- Analysis, Nevirapine -- Research, Physical fitness -- Research -- Analysis -- Reports, Health
Abstract

2024 APR 27 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Fresh data on Drugs and Therapies - Antivirals are presented in a [...]

Published
2024

4. Recent Findings from Oswaldo Cruz Foundation (FIOCRUZ) Provides New Insights into Antivirals [Application of Analytical Quality By Design (Aqbd) for Stability-indicating Method Development for Quantification of Nevirapine and Its Degradation ...]

Subjects
Antiviral agents -- Research, Liquid chromatography -- Research -- Methods, Nevirapine -- Research, Physical fitness -- Methods -- Research, Health
Abstract

2024 APR 6 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Current study results on Drugs and Therapies - Antivirals have been published. [...]

Published
2024

5. Studies Conducted at Department of Pharmaceutical on Antivirals Recently Reported (Preparation of Crystallinity Tailored Silk Fibroin-sodium Alginate Based Floating Microbeads for Nevirapine Delivery)

Subjects
Antiviral agents -- Research, Silk -- Research, Nevirapine -- Research, Physical fitness -- Research, Health
Abstract

2023 SEP 23 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Data detailed on Drugs and Therapies - Antivirals have been presented. According [...]

Published
2023

6. Reports Outline Molecular Recognition Study Results from Sapienza University of Rome (Molecular Recognition of the HPLC Whelk-O1 Selector towards the Conformational Enantiomers of Nevirapine and Oxcarbazepine)

Subjects
Antiviral agents -- Research, High performance liquid chromatography -- Research, Enantiomers -- Research, Nevirapine -- Research, Physical fitness -- Research, Health
Abstract

2021 JAN 16 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Current study results on Nanotechnology - Molecular Recognition have been published. According [...]

Published
2021

7. Studies from Southeast University in the Area of Antivirals Described (LC-MS/MS Quantification of Nevirapine and Its Metabolites in Hair for Assessing Long-Term Adherence)

Subjects
Physical fitness -- Research -- Analysis, Metabolites -- Analysis -- Research, Nevirapine -- Research, Health
Abstract

2020 DEC 19 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Current study results on Drugs and Therapies - Antivirals have been published. [...]

Published
2020

8. Findings from Cape Peninsula University of Technology in the Area of Nanocomposites Reported (Application of Mwcnt/ag-pt Nanocomposite Modified Gce for the Detection of Nevirapine In Pharmaceutical Formulation and Biological Samples)

Subjects
Physical fitness -- Research, Nevirapine -- Research, Nanotechnology -- Research, Antiretroviral agents -- Research, Health
Abstract

2020 NOV 28 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Investigators discuss new findings in Nanotechnology - Nanocomposites. According to news reporting [...]

Published
2020

9. New Findings from Dibrugarh University Describe Advances in Nanoparticles (Surface-modified Polycaprolactone Nanoparticles for the Brain-targeted Delivery of Nevirapine)

Subjects
Nanoparticles -- Research, Low density lipoproteins -- Research, Physical fitness -- Research, Nevirapine -- Research, Nanotechnology -- Research, Antiretroviral agents -- Research, Polycaprolactone -- Research, Health
Abstract

2020 JUN 27 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Current study results on Nanotechnology - Nanoparticles have been published. According to [...]

Published
2020

10. Findings on Antivirals Discussed by Investigators at Federal University (New Multicomponent Forms of the Antiretroviral Nevirapine With Improved Dissolution Performance)

Subjects
Highly active antiretroviral therapy, Physical fitness, Nevirapine -- Research, Antiretroviral agents -- Research, Obesity, Reverse transcriptase inhibitors, International cooperation, Editors, Antiviral agents, Health
Abstract

2020 APR 4 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Data detailed on Drugs and Therapies - Antivirals have been presented. According [...]

Published
2020

11. Study Findings on HIV/AIDS Discussed by Researchers at Huangshan University (Me-Better Drug Design Based on Nevirapine and Mechanism of Molecular Interactions with Y188C Mutant HIV-1 Reverse Transcriptase)

Subjects
HIV (Viruses) -- Research, Antiviral agents -- Research, Drug interactions -- Reports -- Research -- Analysis, Nevirapine -- Research, DNA polymerases -- Research -- Analysis -- Reports, Health
Abstract

2022 NOV 28 (NewsRx) -- By a News Reporter-Staff News Editor at AIDS Weekly -- Research findings on HIV/AIDS are discussed in a new report. According to news reporting originating [...]

Published
2022

12. Research Data from Sinhgad College of Pharmacy Update Understanding of HIV/AIDS (Development and In-vitro In-vivo Characterization of In-situ Gelling Sustained-release Nevirapine Suspension)

Subjects
Antiviral agents -- Research, Pharmacy -- Research, Nevirapine -- Research, Health, Viramune (Medication) -- Research
Abstract

2022 NOV 21 (NewsRx) -- By a News Reporter-Staff News Editor at AIDS Weekly -- Fresh data on Immune System Diseases and Conditions - HIV/AIDS are presented in a new [...]

Published
2022

13. Study Results from University of Shandong Broaden Understanding of Thyroid Cancer (Nevirapine inhibits migration and invasion in dedifferentiated thyroid cancer cells)

Subjects
Thyroid cancer -- Research, Physical fitness, Cancer research, Nevirapine -- Research, Antiretroviral agents -- Research, Thyroid gland, Cancer metastasis -- Research, Cancer cells, Recurrence (Disease), Reverse transcriptase inhibitors, Thyroid diseases, Editors, Health
Abstract

2019 NOV 9 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Current study results on Oncology - Thyroid Cancer have been published. According [...]

Published
2019

14. New HIV/AIDS Findings from Sinhgad College of Pharmacy Described (development and In-vitro In-vivo Characterization of In-situ Gelling Sustained-release Nevirapine Suspension)

Subjects
Medical research, Medicine, Experimental, Antiviral agents -- Research, Pharmacy -- Research, Nevirapine -- Research, Health, Viramune (Medication) -- Research
Abstract

2022 MAY 30 (NewsRx) -- By a News Reporter-Staff News Editor at AIDS Weekly -- Investigators discuss new findings in Immune System Diseases and Conditions - HIV/AIDS. According to news [...]

Published
2022

15. Nevirapine resistance by timing of HIV type 1 infection infants treated with single-dose nevirapine

Author

Micek, Mark A., Blanco, Ana Judith, Beck, Ingrid A., Dross, Sandra, Matunha, Laurinda, Montoya, Pablo, Seidel, Kristy, Gantt, Soren, Matediane, Eduardo, Jamisse, Lilia, Gloyd, Stephen, and Frenkel, Lisa M.

Subjects
HIV infection in children -- Care and treatment, HIV infection in children -- Research, Nevirapine -- Dosage and administration, Nevirapine -- Research, Drug resistance in microorganisms -- Demographic aspects, Drug resistance in microorganisms -- Research, Health, Health care industry
Published
2010

16. Efficacy and safety of 1-month postpartum zidovudine-didanosine to prevent HIV-resistance mutations after intrapartum single-dose nevirapine

Author

Lallemant, Marc, Ngo-Giang-Huong, Nicole, Jourdain, Gonzague, Traisaithit, Patrinee, Cressey, Tim R., Collins, Intira J., Jarupanich, Tapnarong, Sukhumanant, Thammanoon, Achalapong, Jullapong, Sabsanong, Prapan, Chotivanich, Nantasak, Winiyakul, Narong, Ariyadej, Surabon, Kanjanasing, Annop, Ratanakosol, Janyaporn, Hemvuttiphan, Jittapol, Kengsakul, Karun, Wannapira, Wiroj, Sittipiyasakul, Veerachai, Pornkitprasarn, Witaya, Liampongsabuddhi, Prateung, McIntosh, Kenneth, Van Dyke, Russell B., Frenkel, Lisa M., Koetsawang, Suporn, Le Coeur, Sophie, and Kanchana, Siripon

Subjects
HIV infection -- Drug therapy, HIV infection -- Prevention, HIV infection -- Research, Zidovudine -- Dosage and administration, Zidovudine -- Research, Didanosine -- Dosage and administration, Didanosine -- Research, Nevirapine -- Dosage and administration, Nevirapine -- Research, Drug resistance -- Genetic aspects, Drug resistance -- Research, Gene mutations -- Research, Health, Health care industry
Published
2010

17. Substitution of nevirapine because of efavirenz toxicity in AIDS clinical trials group A5095

Author

Schouten, Jeffrey T., Krambrink, Amy, Ribaudo, Heather J., Kmack, Anne, Webb, Nancy, Shikuma, Cecilia, Kuritzkes, Daniel R., and Gulick, Roy M.

Subjects
Nevirapine -- Dosage and administration, Nevirapine -- Research, Efavirenz -- Complications and side effects, Efavirenz -- Research, AIDS (Disease) -- Care and treatment, AIDS (Disease) -- Patient outcomes, AIDS (Disease) -- Research, Health, Health care industry
Published
2010

18. Improvement of mitochondrial toxicity in patients receiving a nucleoside reverse-transcriptase inhibitor-sparing strategy: results from the Multicenter Study with Nevirapine and Kaletra (MULTINEKA)

Author

Negredo, Eugenia, Miro, Oscar, Rodriguez-Santiago, Benjami, Garrabou, Gloria, Estany, Carla, Masabeu, Angels, Force, Lluis, Barrufet, Pilar, Cucurull, Josep, Domingo, Pere, Alonso-Villaverde, Carlos, Bonjoch, Anna, Moren, Constanza, Perez-Alvarez, Nuria, and Clotet, Bonaventura

Subjects
Nevirapine -- Dosage and administration, Nevirapine -- Research, Bone densitometry -- Usage, HIV infection -- Care and treatment, HIV infection -- Research, Mitochondrial diseases -- Care and treatment, Mitochondrial diseases -- Research, Reverse transcriptase inhibitors -- Dosage and administration, Reverse transcriptase inhibitors -- Research, Lipodystrophy -- Risk factors, Lipodystrophy -- Research, Health, Health care industry
Published
2009

19. Antiretroviral resistance patterns and HIV-1 subtype in mother-infant pairs after the administration of combination short-course zidovudine plus single-dose nevirapine for the prevention of mother-to-child transmission of HIV

Author

Chalermchockcharoenkit, Amphan, Culnane, Mary, Chotpitayasunondh, Tawee, Vanprapa, Nirun, Leelawiwat, Wanna, Mock, Philip A., Asavapiriyanont, Suvanna, Teeraratkul, Achara, McConnell, Michelle S., McNicholl, Janet M., and Tappero, Jordan W.

Subjects
HIV infection in children -- Care and treatment, HIV infection in children -- Research, Zidovudine -- Dosage and administration, Zidovudine -- Research, Nevirapine -- Dosage and administration, Nevirapine -- Research, Drug therapy, Combination -- Research, Perinatal infection -- Prevention, Perinatal infection -- Research, Practice guidelines (Medicine) -- Research, Health, Health care industry
Published
2009

20. Persistence of neviparine in breast milk after discontinuation of treatment

Author

Bennetto-Hood, Chantelle, Aldrovandi, Grace M., King, Jennifer R., Woodman, Kyra, Ashouri, Negar, and Acosta, Edward P.

Subjects
Nevirapine -- Research, Breast milk -- Analysis, HIV infection in children -- Causes of, HIV infection in children -- Prevention, Health, Health care industry
Published
2007

21. Weight and body shape changes in a treatment-naive population after 6 months of nevirapine-based generic highly active antiretroviral therapy in South India

Author

Saghayam, Suneeta, Kumarasamy, N., Cecelia, Anitha J., Solomon, Suniti, Mayer, Kenneth, and Wanke, Christine

Subjects
Highly active antiretroviral therapy -- Patient outcomes, Highly active antiretroviral therapy -- Physiological aspects, Highly active antiretroviral therapy -- Research, Nevirapine -- Research, Body size -- Evaluation, Health, Health care industry
Published
2007

22. New Findings on Antiretrovirals Described by Investigators at Banaras Hindu University (Determination of the Anti-HIV Drug Nevirapine Using Electroactive 2D Material Pd@rGO Decorated with MoS2 Quantum Dots)

Subjects
Physical fitness, Nevirapine -- Research, HIV -- Research -- Drug therapy, Palladium, Antiretroviral agents -- Research, Health
Abstract

2018 JUN 23 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Current study results on Drugs and Therapies - Antiretrovirals have been published. [...]

Published
2018

23. Pharmacogenetics of nevirapine-associated hepatotoxicity: an adult AIDS clinical trials group collaboration

Author

Haas, David W., Bartlett, John A., Andersen, Janet W., Sanne, Ian, Wilkinson, Grant R., Hinkle, John, Rousseau, Franck, Ingram, Christiana D., Shaw, Audrey, Lederman, Michael M., and Kim, Richard B.

Subjects
AIDS (Disease) -- Research, Nevirapine -- Health aspects, Nevirapine -- Research, Nevirapine -- Complications and side effects, CD4 lymphocytes -- Research, CD4 lymphocytes -- Physiological aspects, Health, Health care industry
Published
2006

24. Switch from efavirenz to nevirapine associated with resolution of efavirenz-related neuropsychiatric adverse events and improvement in lipid profiles

Author

Ward, Douglas J. and Curtin, John M.

Subjects
Antiviral agents -- Complications and side effects, Antiviral agents -- Research, HIV infection -- Drug therapy, HIV infection -- Research, Nevirapine -- Usage, Nevirapine -- Research, Health
Abstract

In a large HIV-specialty private practice, patients with undetectable or low-grade-positive viral loads with neuropsychiatric side effects or elevated lipids were switched from efavirenz-to nevirapine-based antiretroviral regimens. This is a retrospective analysis of virologic efficacy and changes in adverse neuropsychiatric effects and serum lipid levels after this switch. Forty patients were evaluated. Thirty-six had undetectable viral loads prior to the treatment switch, and their levels remained undetectable after the switch for a median of 25 months (range, 6 to 59 months). Four patients had persistently low-grade-positive viral loads before the switch; viral loads in two of the four patients remained low-grade-positive, while the levels in two patients became undetectable. Twenty patients reporting neuropsychiatric symptoms (depression, anxiety, or fatigue with or without sleep disturbances) before the switch demonstrated significant improvement, with complete resolution of symptoms in 15 patients. Four patients with isolated sleep disturbances had significant improvement. No rash developed in any patient during the switch. Mean lipid levels improved significantly following the switch. Mean total cholesterol decreased 17.8 mg/dL; low-density lipoprotein cholesterol decreased 25.5 mg/dL; triglycerides decreased 70.1 mg/dL; and high-density lipoprotein cholesterol increased 5.3 mg/dL (all p < 0.05). These results demonstrate that patients who are virologically controlled on efavirenz-containing regimens with treatment-associated side effects can be successfully switched to nevirapine-containing therapy with maintenance of virologic control, reduction in neuropsychiatric side effects, and improvement in dyslipidemia.

Published
2006

25. Optimizing treatment for HIV-infected South African women exposed to single-dose nevirapine: balancing efficacy and cost

Author

Holmes, Charles B., Zheng, Hui, Martinson, Neil A., Freedberg, Kenneth A., and Walensky, Rochelle P.

Subjects
HIV infection -- Care and treatment, HIV infection -- Economic aspects, Nevirapine -- Dosage and administration, Nevirapine -- Complications and side effects, Nevirapine -- Research, Drug resistance in microorganisms -- Research, Women, Black -- Drug therapy, Cost benefit analysis -- Research, Cost benefit analysis, Health, Health care industry
Published
2006

26. Distinct patterns of emergence and fading of K103N and Y181C in women with subtype A vs. D after single-dose nevirapine: HIVNET 012

Author

Eshleman, Susan H., Jing Wang, Brown, Elizabeth R., Mmiro, Francis, Jackson, J. Brooks, Guay, Laura A., Mwatha, Anthony, and Musoke, Philippa

Subjects
Nevirapine -- Research, Nevirapine -- Dosage and administration, HIV infection -- Drug therapy, HIV infection in children -- Prevention, Health
Abstract

A study demonstrates that HIV-1 subtype can influence emergence and fading of specific nevirapine resistance (NVPR) mutations after single-dose NVP exposure. Rapid fading of variants with Y181C mutation was observed for women with subtype A, but not for women with subtype D.

Published
2005

27. Plasma HIV-1 RNA decline within the first two weeks of treatment is comparable for nevirapine, efavirenz, or both drugs combined and is not predictive of long-term virologic efficacy: A 2NN substudy

Author

Leth, Frank van, Huisamen, Casper B., Wit, Ferdinand W. N. M., Badaro, Roberto, Lange, Joep M. A., Hall, David B., Vandercam, Bernard, Wet, Joss de, and Montaner, Julio S. G.

Subjects
Nevirapine -- Research, RNA -- Research, Health, Efavirenz (Medication) -- Research
Abstract

An interim analysis based on the data from the first 400 patients to assess possible differences in plasma HIV-1RNA (pVL) decline between the treatment groups is presented. A similar rate of initial decline of pVL for nevirapine (NVP), efavirenz (EFV), and NVP + EFV after adjusting for baseline pVL and region is shown.

Published
2005

28. Persistence of nevirapine exposure during the postpartum period after intrapartum single-dose nevirapine in addition to zidovudine prophylaxis for the prevention of mother-child transmission of HIV-1

Author

Cressey, Tim R., Lallemant, Marc J., Jourdain, Gonzague, Mircochnick, Mark, Kunkeaw, Suparat, Capparelli, Edmund, Jackson, J. Brooks, and Musoke, Philippa

Subjects
Pharmacokinetics -- Research, HIV infection in children -- Prevention, Nevirapine -- Dosage and administration, Nevirapine -- Research, Health
Abstract

Nevirapine (NVP) plasma levels during the postpartum period after a single intrapartum NVP dose for the prevention of mother-to-child transmission is determined. Plasma NVP concentrations around the IC(super 50) might persist in some women for as long as 4 weeks after administration of single intrapartum NVP doses.

Published
2005

29. Long-term efficacy and safety of protease inhibitor switching to nevirapine in HIV-infected patients with undetectable virus load

Author

Gil, Paloma, de Gorgolas, Miguel, Estrada, Vicente, Arranz, Alberto, Rivas, Pablo, Yera, Carmen, Garcia, Rosa, Granizo, Juan J., and Fernandez-Guerrero, Manuel

Subjects
HIV (Viruses) -- Research, Nevirapine -- Research, Nevirapine -- Dosage and administration, Protease inhibitors -- Dosage and administration, Protease inhibitors -- Research, Health, Health care industry
Published
2004

30. Intrapartum exposure to nevirapine and subsequent maternal responses to nevirapine-based antiretroviral therapy

Author

Kantipong, Pacharee, Leechanachai, Pranee, Ariyadej, Surabhon, Leenasirimakul, Prattana, Hammer, Scott, Jourdain, Gonzague, Lallemant, Marc, Ngo-Giang-Huong Nicole, Bowownwatanuwong, Chureeratana, and Le Coeur, Sophie

Subjects
HIV (Viruses) -- Drug therapy, HIV (Viruses) -- Research, Nevirapine -- Dosage and administration, Nevirapine -- Research, Communicable diseases -- Prevention, Communicable diseases -- Research, Antiviral agents -- Dosage and administration, Antiviral agents -- Research
Abstract

Intrapartum nevirapine or placebo was given to 1844 Thai women who had received zidovudine in the third trimester of pregnancy. The results show that both antiretroviral prophylaxis and antiretroviral therapy are beneficial against mother-to-child transmission of human immunodeficiency virus (HIV).

Published
2004

31. Maternal toxicity with continuous Nevirapine in pregnancy

Author

Hitti, Jane, McNamara, James, Sharon Huang, Frenkel, Lisa, Watts, D. Heather, Gandia, Jorge, Stek, Alice M., Stevens, Laura M., Foca, Marc, Nachman, Sharon A., Lee-Jen Wei, Paul, Mary E., Baker, David, Gonzalez-Garcia, Adolfo, Provisor, Arthur, and Thorpe, Edwin M.

Subjects
Nevirapine -- Research, AIDS (Disease) in children -- Research, AIDS (Disease) in children -- Care and treatment, Pregnant women -- Research, Health
Abstract

A study was made by Pediatric AIDS Clinical Trials group Protocol 1022, where 38 antiretroviral-naive was randomly conducted on pregnant women at 10-30 weeks' gestation to nelfinavir or nevirapine with zidovudine plus lamivudine. Greater than expected toxicity and changes in nevirapine prescription was found and hence the study was suspended, showing results of toxicity seen 1 (5%) of 21 subjects randomized to nelfinavir and 5 (29%) of 17 subjects randomized to nevirapine (P = 0.07).

Published
2004

32. Serious adverse coetaneous and hepatic toxicities associated with Nevirapine use by non-HIV-infected individuals

Author

Patel, Shilpa M., Johnson, Stuart, Belknap, Steven M., Chan, Juliana, D, Pharm, Sha, Beverly E., and Bennett, Charles

Subjects
Nevirapine -- Research, HIV (Viruses) -- Research, HIV patients -- Care and treatment, HIV patients -- Research, Health
Abstract

The clinical features of cutaneous and hepatic toxicity that occur when nevirapine is administered to non-HIV-infected individuals are examined. The non-HIV-infected individuals suffer from greater rate of hepatotoxicity than the HIV-infected persons

Published
2004

33. Detection of Nevirapine in plasma using thin-layer chromatography

Author

Dubuisson, Jeffrey G., King, Jennifer R., Stringer, Jeffrey S.A., Bennetto, Chantelle, Acosta, Edward P., and Turner, Michele L.

Subjects
HIV patients -- Research, Chromatography -- Research, Nevirapine -- Research, HIV (Viruses) -- Research, Health
Abstract

The presence of Nevirapine in plasma can be measured by thin-layer chromatography (TCL), which is an economical tool. The prevention of mother-to-child transmission of HIV is possible with the use of NVP in developing-world regions.

Published
2004

34. Characterization of Nevirapine resistance mutations in women with subtype A Vs. D HIV-1 6-8 weeks after single-dose Nevirapine (HIVNET 012)

Author

Eshleman, Susan H., Mwatha, Anthony,;, Brown, Elizabeth R., Guay, Laura A., Cunninggham, Shawn P., Musoke, Philippa, MBChB, Mmiro, Francis, and Jackson, J. Brooks

Subjects
HIV (Viruses) -- Research, HIV patients -- Research, Nevirapine -- Properties, Nevirapine -- Research, Health
Abstract

The study reveals the comparison between number and type of nevirapine (NVP) detected in Uganda women with subtype A vs. D HIV-1 infection after single-dose NVP prophylaxis. Result of the study confirms a higher rate of NVPR in women with subtype D than A.

Published
2004

35. Low rate of mother-to-child transmission of HIV-1 after nevirapine intervention in a pilot public health program in Yaounde, Cameroon

Author

Ayouba, Ahidjo, Tene, Gilbert, Cunin, Patrick, Foupouapouognigni, Yacouba, Menu, Elisabeth, Kfutwah, Anfumbom, Thonnon, Jocelyn, Scarlatti, Gabriella, Monny-Lobe, Marcel, Eteki, Nicole, Kouanfack, Charles, Tardy, Michele, Leke, Robert, Nkam, Maurice, Nlend, Anne E., Barre-Sinoussi, Francoise, Martin, Paul M.V., and Nerrienet, Eric

Subjects
Yaounde, Cameroon -- Health aspects, HIV infection -- Research, HIV infection -- Care and treatment, Nevirapine -- Research, Maternal-fetal exchange -- Research, Health
Published
2003

36. Impact of nevirapine on lipid metabolism

Author

Clotet, Bonaventura, Valk, Marc van der, Negredo, Eugenia, and Reiss, Peter

Subjects
Lipid metabolism -- Research, Nevirapine -- Research, Coronary heart disease -- Research, Coronary heart disease -- Care and treatment, Health
Published
2003

45. Department of Pharmacology and Toxicology Researchers Detail New Studies and Findings in the Area of HIV/AIDS [International Normalized Ratio (INR) Increases amongst Two Patients Living with HIV on Warfarin after Being Switched from a Nevirapine ...]

Subjects
HIV (Viruses) -- Research -- Care and treatment, Anticoagulants (Medicine) -- Research, Pharmacology -- Research, HIV patients -- Care and treatment, Nevirapine -- Research, Health
Abstract

2021 NOV 22 (NewsRx) -- By a News Reporter-Staff News Editor at AIDS Weekly -- Data detailed on HIV/AIDS have been presented. According to news reporting originating from the Department [...]

Published
2021

46. Associations between CYP2B6 polymorphisms and pharmacokinetics after a single dose of nevirapine or efavirenz in African Americans

Author

Haas, David W., Gebretsadik, Tebeb, Mayo, Gail, Menon, Usha N., Acota, Edward P., Shintani, Ayumi, Floyd, Michael, Stein, C. Michael, and Wilkinson, Grant R.

Subjects
HIV infection -- Care and treatment, HIV infection -- Patient outcomes, HIV infection -- Genetic aspects, HIV infection -- Research, Nevirapine -- Dosage and administration, Nevirapine -- Genetic aspects, Nevirapine -- Research, Efavirenz -- Dosage and administration, Efavirenz -- Genetic aspects, Efavirenz -- Research, Pharmacokinetics -- Research, Genetic polymorphisms -- Research, Health
Published
2009

47. Investigators from Western University Target HIV/AIDS (Efficacy of Mobile Phone Use On Adherence To Nevirapine Prophylaxis and Retention In Care Among the Hiv-exposed Infants In Prevention of Mother To Child Transmission of Hiv: a Randomized ...)

Subjects
AstraZeneca PLC, HIV (Viruses) -- Research -- Drug therapy, Medical research, Medicine, Experimental, Infants -- Patient outcomes -- Research, Highly active antiretroviral therapy -- Research, Nevirapine -- Research, Pharmaceutical industry -- Research, Health
Abstract

2021 JUN 7 (NewsRx) -- By a News Reporter-Staff News Editor at AIDS Weekly -- Current study results on Immune System Diseases and Conditions - HIV/AIDS have been published. According [...]

Published
2021

48. Effects of nevirapine, compared with lamivudine, on lipids and lipoproteins in HIV-1-uninfected newborns: the stopping infection from mother-to-child via breast-feeding in Africa Lipid Substudy

Author

Sankatsing, Raaj R., Wit, Ferdinand W., Pakker, Nadine, Vyankandondera, Joseph, Mmiro, Francis, Okong, Pius, Kastelein, John J., Lange, Joep M., Stroes, Erik S., and Reiss, Peter

Subjects
Nevirapine -- Research, Lamivudine -- Research, Lipids -- Physiological aspects, Lipoproteins -- Physiological aspects, Proteolipids -- Physiological aspects, HIV infection -- Development and progression, HIV infection -- Prevention, Breast feeding -- Health aspects, Breast feeding -- Research, Health
Published
2007

Catalog

Books, media, physical & digital resources
See catalog results